DEPOMED INC (DEPO) Stock Price, Quote, News and Overview
NASDAQ:DEPO - Nasdaq - US2499081048
DEPO Quote, Performance and Key Statistics
7.3
+0.12 (+1.67%)
The current stock price of DEPO is 7.3 null. In the past month the price decreased by -11.62%. In the past year, price increased by 11.45%.
About DEPO
Company Profile
Depomed, Inc. is a specialty pharmaceutical company utilizing its innovative AcuForm drug delivery technology to develop novel oral products and improved, extended release formulations of existing oral drugs. AcuForm-based products are designed to provide once- daily administration and reduced side effects, improving patient convenience, compliance and pharmacokinetic profiles. ProQuin XR extended-release tablets have been approved by the FDA for the once-daily treatment of uncomplicated urinary tract infections and are currently being marketed in the United States. In addition, once-daily Glumetza has been approved for use in adults with type two diabetes and is currently being marketed in the United States and Canada. The company is currently evaluating Gabapentin GR for the treatment of two pain indications, postherpetic neuralgia and diabetic peripheral neuropathy, and menopausal hot flashes.
Company Info
DEPOMED INC
7999 GATEWAY BLVD. SUITE 300
NEWARK CA 94560
CEO: Arthur J. Higgins
Phone: 510-744-8000
DEPOMED INC / DEPO FAQ
What is the stock price of DEPOMED INC today?
The current stock price of DEPO is 7.3 null. The price increased by 1.67% in the last trading session.
What is the ticker symbol for DEPOMED INC stock?
The exchange symbol of DEPOMED INC is DEPO and it is listed on the Nasdaq exchange.
On which exchange is DEPO stock listed?
DEPO stock is listed on the Nasdaq exchange.
What is DEPOMED INC worth?
DEPOMED INC (DEPO) has a market capitalization of 466.62M null. This makes DEPO a Small Cap stock.
What are the support and resistance levels for DEPOMED INC (DEPO) stock?
DEPOMED INC (DEPO) has a support level at 7.21. Check the full technical report for a detailed analysis of DEPO support and resistance levels.
Should I buy DEPOMED INC (DEPO) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of DEPO, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of DEPO, evaluating the profitability, health, valuation and growth aspects
- DEPOMED INC (DEPO) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- DEPOMED INC (DEPO) Sales and EPS estimates to see what analysts future expectations are.
- DEPOMED INC (DEPO) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- DEPOMED INC (DEPO) Insider and Institutional Ownership to learn about the owners and their transactions.
- DEPOMED INC (DEPO) Stock Chart to make your own analysis
- DEPOMED INC (DEPO) Latest news and press-releases to stay up to date.
Does DEPOMED INC (DEPO) stock pay dividends?
DEPO does not pay a dividend.
What is the Price/Earnings (PE) ratio of DEPOMED INC (DEPO)?
DEPOMED INC (DEPO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.48).
DEPO Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to DEPO. When comparing the yearly performance of all stocks, DEPO turns out to be only a medium performer in the overall market: it outperformed 58.26% of all stocks.
DEPO Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to DEPO. DEPO has a medium profitability rating, but doesn't score so well on its financial health evaluation.
DEPO Financial Highlights
Over the last trailing twelve months DEPO reported a non-GAAP Earnings per Share(EPS) of -0.48000000000000004. The EPS increased by 13.1% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -9.52% | ||
| ROA | -3.98% | ||
| ROE | -19% | ||
| Debt/Equity | 1.03 |